Format

Send to

Choose Destination
See comment in PubMed Commons below
Nat Rev Immunol. 2006 May;6(5):358-70.

Statin therapy and autoimmune disease: from protein prenylation to immunomodulation.

Author information

1
Department of Cell Biology, Institute of Ophthalmology, University College London, London EC1V 9EL, UK. j.greenwood@ucl.ac.uk

Abstract

Statins have been prescribed extensively for their cholesterol-lowering properties and efficacy in cardiovascular disease. However, compelling evidence now exists that statins also have extensive immunomodulatory properties that operate independently of lipid lowering. Consequently, much attention has been directed towards their potential as therapeutic agents for the treatment of autoimmune disease. Modulation of post-translational protein prenylation seems to be a key mechanism by which statins alter immune function. In this Review, the effect of statin therapy on immune function, and how this relates to the pathogenesis of autoimmune disease, is reviewed alongside current opinion of what the key biological targets of statins are.

PMID:
16639429
PMCID:
PMC3842637
DOI:
10.1038/nri1839
[Indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Nature Publishing Group Icon for PubMed Central
    Loading ...
    Support Center